Filamin A stabilizes FcγRI surface expression and prevents its lysosomal routing

被引:34
作者
Beekman, Jeffrey M. [1 ]
van der Poel, Cees E. [1 ]
van der Linden, Joke A. [1 ]
van den Berg, Debbie L. C. [1 ]
van den Berghe, Peter V. E. [1 ]
van de Winkel, Jan G. J. [1 ,2 ]
Leusen, Jeanette H. W. [1 ]
机构
[1] Univ Med Ctr, Dept Immunol, Immunotherapy Lab, NL-3584 EA Utrecht, Netherlands
[2] Genmab, Utrecht, Netherlands
关键词
D O I
10.4049/jimmunol.180.6.3938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Filamin A, or actin-binding protein 280, is a ubiquitously expressed cytosolic protein that interacts with intracellular domains of multiple receptors to control their subcellular distribution, and signaling capacity. In this study, we document interaction between Fc gamma RI, a high-affinity IgG receptor, and filamin A by yeast two-hybrid techniques and coimmunoprecipitation. Both proteins colocalized at the plasma membrane in monocytes, but dissociated upon Fc gamma RI triggering. The filamin-deficient cell line M2 and a filamin-reconstituted M2 subclone (A7), were used to further study Fc gamma RI-filamin interactions. Fc gamma RI transfection in A7 cells with filamin resulted in high plasma membrane expression levels. In filamin-deficient M2 cells and in filamin RNA-interference studies, Fc gamma RI surface expression was consistently reduced. Fc gamma RI localized to LAMP-1-positive vesicles in the absence of filamin as shown by confocal microscopy indicative for lysosomal localization. Mouse IgG2a capture experiments suggested a transient membrane expression of Fc gamma RI before being transported to the lysosomes. These data support a pivotal role for filamin in Fc gamma RI surface expression via retention of Fc gamma RI from a default lysosomal pathway.
引用
收藏
页码:3938 / 3945
页数:8
相关论文
共 36 条
[1]   Fc-γRI-deficient mice show multiple alterations to inflammatory and immune responses [J].
Barnes, N ;
Gavin, AL ;
Tan, PS ;
Mottram, P ;
Koentgen, F ;
Hogarth, PM .
IMMUNITY, 2002, 16 (03) :379-389
[2]   Modulation of FcγRI (CD64) ligand binding by blocking peptides of periplakin [J].
Beekman, JM ;
Bakema, JE ;
van der Linden, J ;
Tops, B ;
Hinten, M ;
van Vugt, M ;
van de Winkel, JGJ ;
Leusen, JHW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) :33875-33881
[3]   Direct interaction between FcγR1 (CD64) and periplakin controls receptor endocytosis and ligand binding capacity [J].
Beekman, JM ;
Bakema, JE ;
van de Winkel, JGJ ;
Leusen, JHW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10392-10397
[4]   ACTIN-BINDING PROTEIN REQUIREMENT FOR CORTICAL STABILITY AND EFFICIENT LOCOMOTION [J].
CUNNINGHAM, CC ;
GORLIN, JB ;
KWIATKOWSKI, DJ ;
HARTWIG, JH ;
JANMEY, PA ;
BYERS, HR ;
STOSSEL, TP .
SCIENCE, 1992, 255 (5042) :325-327
[5]   The cytoplasmic domain of human FcγRIa alters the functional properties of the FcγRI•γ-chain receptor complex [J].
Edberg, JC ;
Yee, AMF ;
Rakshit, DS ;
Chang, DJ ;
Gokhale, JA ;
Indik, ZK ;
Schreiber, AD ;
Kimberly, RP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30328-30333
[6]   ASSOCIATION OF THE HIGH-AFFINITY RECEPTOR FOR IGG (FC-GAMMA-RI) WITH THE GAMMA-SUBUNIT OF THE IGE RECEPTOR [J].
ERNST, LK ;
DUCHEMIN, AM ;
ANDERSON, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6023-6027
[7]   Selective interactions between helix VIII of the human μ-opioid receptors and the C terminus of periplakin disrupt G protein activation [J].
Feng, GJ ;
Kellett, E ;
Scorer, CA ;
Wilde, J ;
White, JH ;
Milligan, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :33400-33407
[8]  
HARRISON PT, 1994, J BIOL CHEM, V269, P24396
[9]   Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway [J].
He, HJ ;
Kole, S ;
Kwon, YK ;
Crow, MT ;
Bernier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) :27096-27104
[10]   Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice [J].
Heijnen, IAFM ;
vanVugt, MJ ;
Fanger, NA ;
Graziano, RF ;
deWit, TPM ;
Hofhuis, FMA ;
Guyre, PM ;
Capel, PJA ;
Verbeek, JS ;
vandeWinkel, JGJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :331-338